Replimune Group (REPL) Earnings Date, Estimates & Call Transcripts $5.38 -0.15 (-2.71%) Closing price 04:00 PM EasternExtended Trading$5.42 +0.04 (+0.82%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Replimune Group Earnings Summary Replimune Group posted Q1 2026 earnings on August 7, 2025, reporting an EPS of -$0.95, which missed analysts' consensus estimates of -$0.83 by $0.12. With a trailing EPS of -$3.24, Replimune Group's earnings are expected to grow next year, from ($2.97) to ($2.55) per share. Upcoming Q2 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 7) -$0.83 Actual EPS (Aug. 7) -$0.95 Missed By -$0.12 Q1 2026 Earnings ResourcesQ1 2026 Earnings Report Quarterly Report (10-Q) Press Release (8-K)SEC FilingREPL Upcoming EarningsReplimune Group's next earnings date is estimated for Tuesday, November 11, 2025, based on past reporting schedules. Powered by Get Replimune Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Replimune Group and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataREPL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Replimune Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.85-$0.70-$0.77Q2 20254-$0.87-$0.70-$0.79Q3 20254-$0.88-$0.63-$0.74Q4 20254-$0.90-$0.69-$0.79 FY 2025 15 -$3.50 -$2.72 -$3.08 Q1 20263-$0.92-$0.77-$0.85Q2 20264-$0.96-$0.62-$0.82Q3 20264-$0.95-$0.47-$0.72Q4 20264-$0.97-$0.39-$0.68 Replimune Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/7/2025Q1 2026-$0.83-$0.95 -$0.12-$0.95$0.50M-5/22/2025Q4 2025-$0.75-$0.82 -$0.07-$0.82--2/12/2025Q3 2025-$0.70-$0.79 -$0.09-$0.79--11/12/2024--$0.75-$0.68+$0.07-$0.68--8/8/2024--$0.88-$0.78+$0.10-$0.78--5/16/2024Q4 2024-$0.86-$0.82+$0.04-$0.82--2/8/2024Q3 2024-$0.89-$0.77+$0.12-$0.77--11/7/2023Q2 2024-$0.80-$0.90 -$0.10-$0.90-- Replimune Group Earnings - Frequently Asked Questions When is Replimune Group's earnings date? Replimune Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on REPL's earnings history. Did Replimune Group beat their earnings estimates last quarter? In the previous quarter, Replimune Group (NASDAQ:REPL) missed the analysts' consensus estimate of ($0.83) by $0.12 with a reported earnings per share (EPS) of ($0.95). Learn more on analysts' earnings estimate vs. REPL's actual earnings. How can I view Replimune Group's earnings report? Replimune Group's earnings report can be found in their filing with the SEC. View SEC filing How much profit does Replimune Group generate each year? Replimune Group (NASDAQ:REPL) has a recorded net income of -$247.30 million. REPL has generated -$3.24 earnings per share over the last four quarters. What is Replimune Group's EPS forecast for next year? Replimune Group's earnings are expected to grow from ($2.97) per share to ($2.55) per share in the next year. More Earnings Resources from MarketBeat Related Companies Immunocore Earnings Date Aurinia Pharmaceuticals Earnings Date Cidara Therapeutics Earnings Date WAVE Life Sciences Earnings Date Janux Therapeutics Earnings Date Schrodinger Earnings Date Edgewise Therapeutics Earnings Date Harrow Earnings Date Ardelyx Earnings Date 89BIO Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost Pressures This page (NASDAQ:REPL) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Replimune Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access